INOVIO PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Inovio Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$27.3M, a 23.1% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$119M, a 30.8% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$144M, a 46.2% increase from 2022.
  • Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$268M, a 11.2% increase from 2021.
  • Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$301M, a 143% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$144M +$124M +46.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 -$268M +$33.6M +11.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$301M -$177M -143% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 -$124M -$13M -11.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$111M -$17M -18.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$94.1M -$10.4M -12.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$83.6M -$7.41M -9.72% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$76.2M -$42M -122% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$34.3M +$5.21M +13.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$39.5M -$20M -102% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$19.5M +$3.95M +16.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$23.5M -$1.85M -8.57% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$21.6M -$2.42M -12.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$19.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.